De novo mutation causing sporadic type 2A von Willebrancd's disease: report of three cases
暂无分享,去创建一个
K. Pasi | F. Hill | B. Theophilus | M. Enayat
[1] T. Matsushita,et al. Molecular Mechanism and Classification of von Willebrand Disease , 1995, Thrombosis and Haemostasis.
[2] P. Mannucci,et al. Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method , 1993 .
[3] H. Koyama,et al. Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. , 1993, Blood.
[4] P. Mannucci,et al. Identification of three candidate mutations causing type IIA von Willebrand disease using a rapid, nonradioactive, allele-specific hybridization method. , 1993, Blood.
[5] J. Lavergne,et al. Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[6] Pille Harrison,et al. Characterization of Three Mutations Causing von Willebrand Disease Type IIA in Five Unrelated Families , 1992, Thrombosis and Haemostasis.
[7] H. Saito,et al. Three Distinct Candidate Point Mutations of the von Willebrand Factor Gene in Four Patients with Type IIA von Willebrand Disease , 1992, Thrombosis and Haemostasis.
[8] D. Ginsburg,et al. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. , 1992, The Journal of biological chemistry.
[9] A. Giles,et al. Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease. , 1992, American journal of human genetics.
[10] Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Ware,et al. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[12] J M Sorace,et al. Structure of the gene for human von Willebrand factor. , 1989, The Journal of biological chemistry.
[13] D. Bentley,et al. Direct detection of point mutations by mismatch analysis: application to haemophilia B. , 1989, Nucleic acids research.
[14] D. Ginsburg,et al. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Prowse,et al. Evaluation of Monoclonal Antibodies to vWf Antigen for Use in Autoradiographing vWf Multimer Analysis , 1987, Thrombosis and Haemostasis.
[16] E. Tuddenham,et al. A Two-Site, Monoclonal Antibody-Based Immunoassay for von Willebrand Factor -Demonstration that vWF Function Resides in a Conformational Epitope , 1986, Thrombosis and Haemostasis.
[17] D. Barker,et al. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA , 1984, Cell.
[18] F. Hill,et al. Factor VIII related antigen: an improved enzyme immunoassay. , 1982, Medical laboratory sciences.